Case Studies/Studies

Promising Advance in the Fight Against Alcoholism

Researchers explore a new use for prazosin.


Genomic Structural Variants Discovered in Patients With Schizophrenia

A groundbreaking study reveals an ultra-rare genomic variant often presents in patients with schizophrenia, providing more information on effective treatment options for a complicated disorder.


Different Men, Different Outcomes

A new study may help men make more informed decisions about prostate cancer treatment.


Can a Genetic Signature Predict Which Prostate Cancers Spread?

A new study could lead to better tailoring of treatments to individual patients.


Healthier Lifestyles May Help Explain Long-Term Hip Fracture Decline

A new study finds that decreases in two osteoporosis risk factors — smoking and heavy alcohol use — help account for a steady drop in hip fracture rates in the U.S. over 40 years.


Business of Medicine

Vote of Confidence: Hospital Consumer Comfort in the Era of COVID-19

While COVID-19 caused many to shy away from in-person visits with a healthcare provider, a Healthgrades study published in May notes that consumer confidence is on the upswing. The COVID-19 Patient Confidence Study, a weekly...


A Strategy to Identify Drug-Resistant Bacteria

Game theory could be the key to identifying dangerous antimicrobial-resistant bacteria.


Researchers Pursue a Targeted Treatment for Colitis-Causing Bacteria

Current antibiotic treatments for Clostridioides difficile infection (CDI), which causes the chronic, degenerative disease colitis, eliminate beneficial bacteria in the gut along with the harmful pathogen. Researchers at North Carolina State University (NCSU) have taken the first step toward developing a therapy that attacks C. difficile while sparing other microbes.


Leukemia Drugs for Lung Cancer?

Two recently approved treatments show promise in a new study.


That’s News

A New Combination Therapy for HER2-Positive Metastatic Breast Cancer

The recent FDA approval of the drug Tukysa (tucatinib) for use with the chemotherapeutic agents trastuzumab and capecitabine provides a new treatment option to certain adults with HER2-positive breast cancer.

The...